Zhuangzhuang Zheng Selected Research

Zhuangzhuang Zheng Research Topics

18	Neoplasms (Cancer) 01/2023 - 01/2020
5	Head and Neck Neoplasms (Head and Neck Cancer) 04/2024 - 01/2020
5	Squamous Cell Carcinoma of Head and Neck 01/2024 - 01/2021
4	Hypoxia (Hypoxemia) 05/2022 - 01/2021
3	Carcinogenesis 01/2023 - 08/2022
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2022
2	Inflammation (Inflammations) 01/2023 - 01/2022
2	Glioma (Gliomas) 01/2022 - 01/2021
2	Stomatitis 01/2021 - 01/2020
1	Atrophy 12/2022
1	Fibrosis (Cirrhosis) 12/2022
1	Disease Progression 10/2022
1	Lung Neoplasms (Lung Cancer) 05/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Radiation Injuries (Radiation Sickness) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Iron Overload 01/2022
1	Microsatellite Instability 01/2022
1	Breast Neoplasms (Breast Cancer) 11/2021
1	Malnutrition (Nutritional Deficiencies) 01/2020
1	Anemia 01/2020

4	AntioxidantsIBA 12/2022 - 01/2022
3	apatinibIBA 01/2024 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2020
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2022
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2022 - 07/2021
2	Angiogenesis InhibitorsIBA 10/2022 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 05/2022 - 01/2022
2	Free RadicalsIBA 01/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 07/2021 - 01/2021
1	Histones (Histone)IBA 01/2023
1	Chelating AgentsIBA 01/2023
1	CopperIBA 01/2023
1	AntigensIBA 01/2023
1	Neuroprotective AgentsIBA 01/2023
1	IonophoresIBA 01/2023
1	Shikimic AcidIBA 01/2023
1	sulforaphaneIBA 12/2022
1	CollagenIBA 12/2022
1	Glucose (Dextrose)FDA LinkGeneric 11/2022
1	SeptinsIBA 08/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2022
1	Coenzyme A Ligases (Acid-Thiol Ligases)IBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	pembrolizumabIBA 11/2021
1	PlatinumIBA 11/2021
1	Cetuximab (Erbitux)FDA Link 11/2021
1	InterferonsIBA 07/2021
1	Hypoxia-Inducible Factor 1IBA 07/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021